Picture of Trident Texofab logo

540726 Trident Texofab Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapMomentum Trap

Annual cashflow statement for Trident Texofab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line9.0412.727.311.725.8
Depreciation
Amortisation
Non-Cash Items1931.726.841.421.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital-18.6-45.2-12-42.5-227
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities19.613.958.527.1-163
Capital Expenditures-99.2-41.6-2.17-0.5750
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.78-2.245.89-5.1414.8
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-102-43.83.73-5.7114.8
Financing Cash Flow Items-8.87-21.3-33.9-37.82.43
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities81.929.9-62-20.5180
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.4740.0430.2290.94131.6